Abstract B039: APEX2 is a synthetic lethal target for RNASEH2B-deleted or BRCA-mutant tumorsAntoine Simoneau, Teng Teng, Shangtao Liu et al.|Molecular Cancer Therapeutics|2025Cited by 2
Abstract B098: Unbiased in vitro and in vivo drug anchor screens identify mechanisms of resistance and sensitization for MTA-cooperative PRMT5 inhibitors in MTAP-deleted cancer modelsSteven Lombardo, Teng Teng, Matthew R. Tonini et al.|Molecular Cancer Therapeutics|2023Cited by 0